C29 Metals (ASX:C29) Expands Ulytau Project with New Exploration Licence
C29 Metals (ASX:C29) secures a new exploration licence, expanding the Ulytau Project footprint by 116 km² in Kazakhstan.
C29 Metals (ASX:C29) secures a new exploration licence, expanding the Ulytau Project footprint by 116 km² in Kazakhstan.
Imugene Limited (ASX:IMU) secures FDA Fast Track designation for its allogeneic CAR T-cell therapy azer-cel, advancing treatment for relapsed or refractory diffuse large B-cell lymphoma.
New Zealand King Salmon (ASX:NZK) faces higher sea farm mortality impacting FY26 harvest projections while maintaining FY25 financial guidance.
Orthocell Limited (ASX:OCC) secures Singapore’s regulatory approval for Striate+, boosting its global market expansion and sales growth.
Harvest Lane Asset Management files application with the Takeovers Panel concerning Dropsuite Limited (ASX:DSE)’s shareholder activities amid a proposed acquisition.
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
Thor Energy PLC (ASX:THR) converts its licence to an RSEL, advancing hydrogen and helium exploration projects.
ACCC raises concerns over DP World Australia’s proposed acquisition of Silk Logistics Holdings Limited (ASX:SLH), evaluating potential competition impacts.
Ionic Rare Earths (ASX:IXR) reports up to 61% lower CO₂ emissions from its magnet recycling process and launches MagNetZero TM initiative.
Sarytogan Graphite (ASX:SGA) advances water drilling efforts in Kazakhstan to secure essential water supply for its graphite project.